EDGAR LOPEZ DE CASTRO DELGADO: Open Payments
NPI 1316500762 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$850 in 40 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $407 · 2025 $850
Food & beverage: $741Education: $109
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 16 | $320 |
| Alkermes, Inc. | 6 | $121 |
| Janssen Pharmaceuticals, Inc | 5 | $114 |
| E.R. Squibb & Sons, L.L.C. | 5 | $111 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $86 |
| Neurocrine BioSciences, Inc. | 2 | $65 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
Products named: UZEDY, INVEGA SUSTENNA, COBENFY, ARISTADA, AUSTEDO XR, CAPLYTA, INGREZZA, LYBALVI.
Industry payments across FL — which companies pay providers there.
